NantHealth will be showcasing Baxter’s recently integrated Prismaflex device in the HIMSS Interoperability Showcase in Hall F - Booth #9100, which brings together multiple vendors with kidney and dialysis treatment solutions.
Prismaflex is Rx Only: For safe and proper use of the devices mentioned herein, refer to the complete instructions in the Operator's Manual. The Prismaflex system is intended for continuous renal replacement therapies (CVVHDF, CVVHD, CVVH, SCUF) and therapeutic plasma exchange (TPE). The Prismaflex system should be restricted to patients with a body weight greater than 20 kg (44 lb).
About Acute Kidney Injury
Acute kidney injury (AKI) is a sudden decrease in kidney function over a period of hours to days, often the result of illness, trauma or infection. The sudden loss of kidney function leads to the accumulation of toxins and fluid in the blood that, if left untreated, may lead to death. The most severe stage of AKI requires renal replacement therapy to replace the function of healthy kidneys. AKI is an increasingly common complication of acute illnesses in intensive care units and hospitals.
About NantHealth
NantHealth provides innovative solutions across the continuum of care for patients, physicians, payers and biopharmaceutical organizations. Connected Care, NantHealth’s Medical Device Interoperability (MDI) solution, provides hundreds of healthcare facilities across the globe with vendor-neutral device connectivity. Our combined hardware-software offering delivers high resolution, low-latency medical device data to a broad range of clinical systems, including EMRs and research databases.
Back to HCB News
